Year-End Report — APOTEX CORP. for APOTEX CORP. (2007)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

APOTEX CORP.

Client

APOTEX CORP.

Income

—

Expenses

$248,000

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
Year-End Report (this page)	Feb 7, 2008	$248,000	Replaced
Year-End Amendment	Jul 18, 2008	$250,000	Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Centers for Medicare and Medicaid Services Rule 2238-P concerning Medicaid prescription drug reimbursement S. 1951, Fair Medicaid Drug Payment Act HR 3700, Fair Medicaid Drug Payment Act HR 3140, Saving our Community Pharmacy Act

Lobbyist	Covered position, as disclosed
STEVEN GIULI	N/A
REILLY O'CONNOR	N/A

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3700 (110th), S. 1951 (110th), H.R. 3140 (110th)

Copyright/Patent/Trademark CPT

HR 1908, Patent Reform Act of 2007 S. 1145, Patent Reform Act of 2007

Lobbyist	Covered position, as disclosed
STEVEN GIULI	N/A
REILLY O'CONNOR	N/A

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Budget/Appropriations BUD

HR 3161, FY 2008 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations -- Office of Generic Drug Funding S 1859, FY 2008 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations -- Office of Generic Drug Funding

Lobbyist	Covered position, as disclosed
STEVEN GIULI	N/A
REILLY O'CONNOR	N/A

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE

Bills named: H.R. 3161 (110th)

Pharmacy PHA

S. 316, the Preserve Access to Affordable Pharmaceuticals Act HR 1902, Protecting Consumer Access to Generic Drugs Act HR 1038, Access to Life Savings Medicine Act S. 623, Access to Life Savings Medicine Act

Lobbyist	Covered position, as disclosed
STEVEN GIULI	N/A
REILLY O'CONNOR	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Bills named: H.R. 1902 (110th), S. 623 (110th), S. 316 (110th), H.R. 1038 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.